Inactive Instrument

ICON PLC Share Price Irish S.E.

Equities

ICLR

IE0005711209

Biotechnology & Medical Research

Real-time Estimate Tradegate 17:54:22 27/05/2024 BST 5-day change 1st Jan Change
297.8 EUR +1,385.29% Intraday chart for ICON PLC -8.66% 0.00%

Financials

Sales 2024 * 8.64B 7.96B 677B Sales 2025 * 9.28B 8.55B 727B Capitalization 26.52B 24.43B 2,077B
Net income 2024 * 820M 755M 64.22B Net income 2025 * 1B 921M 78.32B EV / Sales 2024 * 3.33 x
Net Debt 2024 * 2.29B 2.11B 179B Net Debt 2025 * 1.13B 1.04B 88.5B EV / Sales 2025 * 2.98 x
P/E ratio 2024 *
32.4 x
P/E ratio 2025 *
26.7 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.35%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 63 31/10/11
Director of Finance/CFO 45 31/12/05
Chairman 61 02/10/05
Members of the board TitleAgeSince
Founder 71 31/05/90
Chief Executive Officer 63 31/10/11
Director/Board Member 68 30/06/21
More insiders
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
Calendar
30/05/2024 - Investor Day
More about the company